A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Clinical trial NCT01519960 · COMPLETED

Trial details

NCT number: NCT01519960
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2012-07-11
Primary completion: 2015-07-09
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.